Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.5 was added, replacing the prior v3.5.4. This signals an updated version of the study documents on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3, indicating a small update to the page version. There is no indication of substantive changes to study details or sections.SummaryDifference0.0%

- Check33 days agoChange DetectedThere are no recorded changes to summarize for this page. The provided data does not include additions or deletions to interpret in context.SummaryDifference0.0%

- Check40 days agoChange DetectedThe record now shows that the study was terminated and results were posted on 2026-04-27. It also adds updated details about the trial design, primary and secondary endpoints, eligibility criteria, and list of locations.SummaryDifference2%

- Check47 days agoChange DetectedThe page footer revision updated from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check54 days agoChange DetectedUpdated location details: the entry 'Vienna' and 'Vienna, Vienna, Austria, 1090' were replaced with 'Vienna, State of Vienna, Austria, 1090' and an additional 'State of Vienna' designation was added. The previous entries 'Vienna' and 'Vienna, Vienna, Austria, 1090' were removed.SummaryDifference0.2%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.